3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Skin Neoplasms
1
Multiple Sclerosis, Relapsing-Remitting
1
Multiple Sclerosis
1
Melanoma
1
Carcinoma, Basal Cell
1
Interventions
sonidegib
3
Tomography, Optical Coherence
3
Mohs Surgery
3
HhAntag691
3
Imiquimod
2
Blood Specimen Collection
2
teriflunomide
1
cemiplimab
1
Watchful Waiting
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Spectrum Analysis, Raman
1
Predictive Learning Models
1
Patient Reported Outcome Measures
1
Natalizumab
1
Microscopy, Confocal
1
Microarray Analysis
1
Intravital Microscopy
1
Immunotherapy
1
Fingolimod Hydrochloride
1
Dimethyl Fumarate
1
Dermoscopy
1
Biopsy
1
Alemtuzumab
1
Aftercare
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Carcinoma, Basal Cell
×
Natalizumab
×
Clear all
NCT06705608
2024-11-26
MS; FTY720
University of British Columbia
Completed
4,000 enrolled